Immunohistochemical detection of HER1/HER2 can be considered a predictive marker of gefitinib activity in non-small-cell lung cancer? [1]

Cristina Noberasco, Tommaso De Pas, Giuseppe Curigliano, Sara Manzoni, Lucia Dodaro, Giuseppe Pelosi, Lorenzo Spaggtari, Filippo De Braud

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)921-922
Number of pages2
JournalJournal of Clinical Oncology
Issue number4
Publication statusPublished - 2005

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this